SAN FRANCISCO, CA — A new study provides a glimpse of the shift over the past decade in the number of requests for nuclear myocardial perfusion imaging (MPI) tests to determine areas of the heart with ...
A novel PET perfusion radiotracer, 18 F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese patients with a higher sensitivity and specificity compared to 99m Tc-SPECT myocardial ...
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has delivered the first patient doses of Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission ...
GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary artery disease (CAD), compared to SPECT MPI, ...
Researchers have developed a method that leverages artificial intelligence to ensure accurate heart scans without added radiation or cost. Coronary artery disease is the leading cause of death ...
The nuclear stress test can show how blood flows through your heart muscles. This reveals how well the heart pumps blood and areas of your heart muscles that do not get enough blood. Nuclear stress is ...
A stress test can help doctors diagnose certain heart conditions, but it’s a good idea to consider ages when deciding who might undergo this exercise-based screening. Share on Pinterest FG Trade/Getty ...
Detailed price information for GE Healthcare Technologies Inc (GEHC-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback